Wholesale Tesamorelin 5mg Suppliers, Products

Size: 5mg Purity: >99% Form: Lyophilized powder Storage: Lyophilized powder: freeze at -20 °C (-4 °F) or lower; after reconstitution, refrigerate at 2–8 °C Contents: Tesamorelin

Product Description

Tesamorelin 20 mg — Comprehensive Summary
Basic Information
Item Details
Name Tesamorelin
Type GHRH analog (stimulates growth hormone release)
Strength 5mg lyophilized powder
Approved Use HIV-associated lipodystrophy (FDA-approved)
Route Subcutaneous injection (SC)
Reconstitution
Item Method
Solvent 1.0 mL bacteriostatic water
Final Concentration 5.0 mg/mL
Storage Lyophilized powder: refrigerate (2–8 °C)
Reconstituted solution: refrigerate, use under sterile conditions
Common Dosage Reference
Week Dose Micrograms (mcg) U100 Syringe Units Injection Volume (mL)
Week 1 1 mg/day 1000 mcg 20 units 0.20 mL
Week 2+ 2 mg/day 2000 mcg 40 units 0.40 mL
  • Frequency: Once daily, ideally in the evening to match natural GH rhythm.
  • Cycle length: Typically 8–16 weeks, depending on goals and tolerance.
Precautions & Monitoring
1. Tolerance Check

Start at 1 mg/day for the first week, then increase to 2 mg/day.

2. Possible Side Effects

Injection site reactions, joint pain, edema, blood sugar fluctuations.

3. Monitoring

IGF-1 levels, blood glucose, lipids, and overall response.

4. Safety

Use only under medical supervision; maintain sterile technique and proper storage.

Practical Tips
1. U100 Syringe Conversion

1 mL = 100 units

2. Dose-Volume Reference

• 1 mg = 0.20 mL = 20 units
• 2 mg = 0.40 mL = 40 units

Frequently Asked Questions (FAQ)
Q1: What is Tesamorelin and what is its approved use?
Tesamorelin is a Growth Hormone-Releasing Hormone (GHRH) analog that stimulates the natural release of growth hormone. It is FDA-approved for treating HIV-associated lipodystrophy.
Q2: How should Tesamorelin be reconstituted and stored?
Reconstitute the 5 mg lyophilized powder with 1.0 mL of bacteriostatic water to achieve a 5.0 mg/mL concentration. Store lyophilized powder in the refrigerator (2–8 °C). The reconstituted solution must also be kept refrigerated and handled under sterile conditions.
Q3: What is the recommended dosing schedule for Tesamorelin?
The protocol generally starts with a tolerance check of 1 mg/day (20 units / 0.20 mL) in Week 1, increasing to 2 mg/day (40 units / 0.40 mL) starting Week 2. Cycles typically last between 8 to 16 weeks depending on individual goals and tolerance.
Q4: What is the best time and administration route for Tesamorelin?
Tesamorelin is administered via subcutaneous injection (SC) once daily. It is ideally taken in the evening to align with the body's natural nocturnal growth hormone release rhythm.
Q5: What side effects and indicators should be monitored during use?
Possible side effects include injection site reactions, joint pain, edema, and blood sugar fluctuations. Users should regularly monitor IGF-1 levels, blood glucose, lipid profiles, and overall physiological response under professional medical supervision.

Related Products